Atrial Natriuretic Peptide Induces Mitogen-Activated Protein Kinase Phosphatase-1 in Human Endothelial Cells via Rac1 and NAD(P)H Oxidase/Nox2-Activation
- 7 January 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 96 (1) , 43-53
- https://doi.org/10.1161/01.res.0000151983.01148.06
Abstract
The cardiovascular hormone atrial natriuretic peptide (ANP) exerts anti-inflammatory effects on tumor necrosis factor-α–activated endothelial cells by inducing mitogen-activated protein kinase (MAPK) phosphatase-1 (MKP-1). The underlying mechanisms are as yet unknown. We aimed to elucidate the signaling pathways leading to an induction of MKP-1 by ANP in primary human endothelial cells. By using antioxidants, generation of reactive oxygen species (ROS) was shown to be crucially involved in MKP-1 upregulation. ANP was found to increase ROS formation in cultured cells as well as in the endothelium of intact rat lung vessels. We applied NAD(P)H oxidase (Nox) inhibitors (apocynin and gp91ds-tat) and revealed this enzyme complex to be crucial for superoxide generation and MKP-1 expression. Moreover, by performing Nox2/4 antisense experiments, we identified Nox2 as the critically involved Nox homologue. Pull-down assays and confocal microscopy showed that ANP activates the small Rho-GTPase Rac1. Transfection of a dominant-negative (RacN17) and constitutively active Rac1 mutant (RacV12) indicated that ANP-induced superoxide generation and MKP-1 expression are mediated via Rac1 activation. ANP-evoked production of superoxide was found to activate c-Jun N-terminal kinase (JNK). Using specific inhibitors, we linked ANP-induced JNK activation to MKP-1 expression and excluded an involvement of protein kinase C, extracellular signal-regulated kinase, and p38 MAPK. MKP-1 induction was shown to depend on activation of the transcription factor activator protein-1 (AP-1) by using electrophoretic mobility shift assay and AP-1 decoys. In summary, our work provides insights into the mechanisms by which ANP induces MKP-1 and shows that ANP is a novel endogenous activator of endothelial Rac1 and Nox/Nox2.Keywords
This publication has 39 references indexed in Scilit:
- Exogenous nitric oxide generates ROS and induces cardioprotection: involvement of PKG, mitochondrial KATP channels, and ERKAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Targeted Inhibition of p38 Mitogen-activated Protein Kinase Antagonizes Cardiac Injury and Cell Death Following Ischemia-Reperfusion in VivoJournal of Biological Chemistry, 2004
- Dexamethasone regulates AP-1 to repress TNF- induced MCP-1 production in human glomerular endothelial cellsNephrology Dialysis Transplantation, 2004
- Nox4 as the Major Catalytic Component of an Endothelial NAD(P)H OxidaseCirculation, 2004
- ANP inhibits TNF-α-induced endothelial MCP-1 expression—involvement of p38 MAPK and MKP-1Journal of Leukocyte Biology, 2003
- MAP kinase phosphatase 1: a novel mediator of biological effects of glucocorticoids?Journal of Endocrinology, 2003
- Induction of IκB: atrial natriuretic peptide as a regulator of the NF-κB pathwayBiochemical and Biophysical Research Communications, 2002
- Adhesion to Fibronectin Enhances MKP-1 Activation in Human Endothelial CellsBiochemical and Biophysical Research Communications, 2000
- Pressure is proinflammatory in lung venular capillariesJournal of Clinical Investigation, 1999
- Induction of Mitogen-activated Protein Kinase Phosphatase 1 by the Stress-activated Protein Kinase Signaling Pathway but Not by Extracellular Signal-regulated Kinase in FibroblastsJournal of Biological Chemistry, 1996